Jianwei Lan

Tianjin, 300052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

DNASE1L3 regulates macrophage polarization through the NLRP3-GSDMD signaling pathway affecting hepatocellular carcinoma progression.

DNASE1L3 regulates macrophage polarization through the NLRP3-GSDMD signaling pathway affecting hepatocellular carcinoma progression.

Journal: Molecular biology of the cell

Published: November 26, 2025

A lactylation- and autophagy-associated prognostic signature reveals LSEC-derived CLEC3B as a novel mediator of hepatocellular carcinoma suppression.

A lactylation- and autophagy-associated prognostic signature reveals LSEC-derived CLEC3B as a novel mediator of hepatocellular carcinoma suppression.

Journal: PLoS computational biology

Published: October 09, 2025

NAC and DNase I synergistically reduce NETs to attenuate severe acute pancreatitis via suppressing the NETs/NF-κB/CXCL3 pathway.

NAC and DNase I synergistically reduce NETs to attenuate severe acute pancreatitis via suppressing the NETs/NF-κB/CXCL3 pathway.

Journal: Apoptosis : an international journal on programmed cell death

Published: September 26, 2025

Heavy metal exposure and cancer risk: Findings from a Mendelian randomization study.

Heavy metal exposure and cancer risk: Findings from a Mendelian randomization study.

Journal: Toxicology letters

Published: September 12, 2025

Integrative machine learning and multi-omics analysis reveals ATIC as a promoter of hepatocellular carcinoma progression.

Integrative machine learning and multi-omics analysis reveals ATIC as a promoter of hepatocellular carcinoma progression.

Journal: Scientific reports

Published: September 02, 2025

Systematic profiling reveals hepatic immune and metabolic dysregulation in DNASE1L3-deficient mice.

Systematic profiling reveals hepatic immune and metabolic dysregulation in DNASE1L3-deficient mice.

Journal: iScience

Published: June 17, 2025

The Application of a New Model for Disease Classification in Minimally Invasive Treatment of Concomitant Cholecystolithiasis and Choledocholithiasis.

The Application of a New Model for Disease Classification in Minimally Invasive Treatment of Concomitant Cholecystolithiasis and Choledocholithiasis.

Journal: Annali italiani di chirurgia

Published: February 17, 2025

Unraveling the TEC-associated landscape in hepatocellular carcinoma: a comprehensive study based on multi-omics analyses.

Unraveling the TEC-associated landscape in hepatocellular carcinoma: a comprehensive study based on multi-omics analyses.

Journal: Discover oncology

Published: January 16, 2025

Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications.

Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications.

Journal: Discover oncology

Published: December 11, 2024

Metabolites mediate the causal associations between gut microbiota and NAFLD: a Mendelian randomization study.

Metabolites mediate the causal associations between gut microbiota and NAFLD: a Mendelian randomization study.

Journal: BMC gastroenterology

Published: March 16, 2024

FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway.

FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway.

Journal: International journal of biological sciences

Published: December 06, 2021

Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1.

Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1.

Journal: International journal of biological sciences

Published: November 28, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026